Current practice for awake fibreoptic intubation – asking the right questions

We would like to thank Drs. Murphy and Howes for their thoughtful editorial, which accompanied our recent study of awake fibreoptic intubation (AFOI) practice [1, 2], and for recognising the training opportunities that our institution provides. However, rather than alluding to unanswered questions in our data, we are concerned that they have applied conjecture and inference to ask the wrong questions about AFOI. Murphy and Howes assert that ‘placing particular emphasis on any individual component . risks losing sight of the bigger picture’. Just as pilots emphasise training on the most critical phases of flight, so too must clinicians. Efforts must be made to train for complex, procedural skills as well as considering the important, but non-specific, ‘bigger picture’. The question is – how can we excel at all components of the airway management pathway? The simple answer is self-evident in our data: training. Murphy and Howes cite an editorial [3] written by one of our authors. Our prospective study (rather than audit, as there are no accepted standards) has demonstrated that AFOI is associated with low morbidity and a high success rate, particularly when appropriate training is undertaken. Although we do not state that AFOI should be the ‘gold standard’, our data clearly highlights that AFOI has a valuable role to play in the management of the difficult airway. Had Drs. Murphy and Howes put Ahmad and Bailey’s editorial into context [3], they would have understood that training is recommended for AFOI, and when not undertaken, AFOI should be considered a specialist skill. Performed by appropriately trained and competent clinicians, the utility of a technique that has been part of anaesthetic practice for 50 years is difficult to refute. The question here, then, is: who should train in AFOI? We thank the authors for contextualising our prospective data with retrospective results collected in the USA [4] and Canada [5]. Retrospective data points can be under-reported, and the low complication rates reported by Joseph et al. [4] could be an inaccurate representation of their true incidence. Moreover, the comparable complication rates provided by Law et al. [5] might also be underreported. It would be interesting to know what prospective data from North America shows. Comparing our results with data from unsedated, healthy course delegates (a self-selected group of subjects) is misleading [6]. The immediate complication rate in healthy volunteers was greater than we found in comorbid patients with complex airway pathology (19.5% vs. 11% respectively), and so the co-administration of sedation does not necessarily correlate with increased risk. Interestingly, the Difficult Airway Society has recently commissioned national guidelines on the performance of AFOI. Whether sedation will be recommended as standard practice remains to be seen. The question that needs answering here is: does sedation increase or decrease the safety of performing AFOI? We agree that there is insufficient evidence recommending highflow nasal oxygen (HFNO) for all AFOIs. Murphy and Howes infer our data do not demonstrate that